Myeloid malignancies induced by alkylating agents in NF1 mice

Blood

Volumn 93, Issue 11, 1999, Pages 3617-3623

  Mahgoub, Nidal ^b   Taylor, Brigit R ^b   Le Beau, Michelle M ^b   Gratiot, Mary ^b   Carlson, Katrin M ^b   Atwater, Susan K ^b   Jacks, Tyler ^b   Shannon, Kevin M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE INHIBITOR; ETOPOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 11; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE INACTIVATION; GENE LOSS; GENOTYPE; HETEROZYGOSITY LOSS; MOUSE; MYELODYSPLASTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0033153116     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.11.3617     Document Type: Article

References (39)

1. Rowley JD, Colomb HM, Vardiman J: Nonrandom chromosomal abnormalities in acute nonlymphocytic leukemia in patients treated for Hodgkin disease and non-Hodgkin lymphoma. Blood 50:759, 1977
2. Le Beau M, Albain KS, Larson RA, Vardiman J, Davis E, Blough R, Golomb H, Rowley J: Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: Further evidence for characteristic abnormalties of chromosomes 5 and 7. J Clin Oncol 3:325, 1986
3. Pedersen-Bjergaard J, Phillip P: Cytogenetic characteristics of therapy-related acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome: Correlation with clinical data in 61 consecutive cases. Br J Hematol 66:199, 1987
4. Pedersen-Bjergaard J, Rowley JD: The balanced and unbalanced chromosomal aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 83:2780, 1994
5. Ratain MJ, Kaminer LS, Bitran JD, Larson RA, Le Beau MM, Skosey C, Rowley JD: Acute nonlymphoblastic leukemia following etoposide and cisplatin combination chemotherapy for advanced small cell carcinoma of the lung. Blood 70:1212, 1987
6. Levine E, Bloomfeld C: Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol 19:47, 1992
7. Pui C-H, Behm FG, Raimondi SC, Dodge RK, George SL, Rivera GK, Mirro JJ, Kalwinsky DK, Dahl GV, Murphy SB, Crist WM, Williams DL: Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med 321:136, 1989
8. Smith MA, Rubinstein L, Ungerleider RS: Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: Estimating the risks. Med Pediatr Oncol 23:86, 1994
9. Riccardi VM, Eichner JE: Neurofibromatosis. Baltimore, MD, Johns Hopkins University Press, 1986
10. Bader JL, Miller RW: Neurofibromatosis and childhood leukemia. J Pediatr 92:925, 1978
11. Stiller CA, Chessells JM, Fitchett M: Neurofibromatosis and childhood leukemia/lymphoma: A population-based UKCCSG study. Br J Cancer 70:969, 1994
12. Arico M, Biondi A, Pui C-H: Juvenile myelomonocytic leukemia. Blood 90:479, 1997
13. Boguski M, McCormick F: Proteins regulating Ras and its relatives. Nature 366:643, 1993
14. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F: Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330:597, 1994
15. ras. Blood 84:3435, 1994
16. Jacks T, Shih S, Schmitt EM, Bronson RT, Bernards A, Weinberg RA: Tumorigenic and developmental consequences of a targeted Nf1 mutation in the mouse. Nature Genet 7:353, 1994
17. Largaespada DA, Brannan CI, Jenkins NA, Copeland NG: Nf1 deficiency causes Ras-mediated granulocyte-macrophage colony stimulating factor hypersensitivity and chronic myeloid leukemia. Nat Genet 12:137, 1996
18. Bollag G, Clapp DW, Shih S, Adler F, Zhang Y, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T, Shannon K: Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in murine and human hematopoietic cells. Nat Genet 12:144, 1996
19. Miles DK, Freedman MH, Stephens K, Pallavicini M, Sievers E, Weaver M, Grunberger T, Thompson P, Shannon KM: Patterns of hematopoietic lineage involvement in children with neurofibromatosis, type 1, and malignant myeloid disorders. Blood 88:4314, 1996
20. Side L, Taylor B, Cayouette M, Connor E, Thompson P, Luce M, Shannon K: Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 336:1713, 1997
21. Maris JM, Wiersma SR, Mahgoub N, Thompson P, Geyer RJ, Lange BJ, Shannon KM: Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1. Cancer 79:1438, 1997
22. Shannon KM, Turhan AG, Chang SSY, Bowcock AM, Rogers PCJ, Carroll WL, Cowan MJ, Glader BE, Eaves CJ, Eaves AC, Kan YW: Familial bone marrow monosomy 7: Evidence that the predisposing locus is not on the long arm of chromosome 7. J Clin Invest 84:984, 1989
23. Cowell JK: A photographic representation of the variability in the G-banded structures of the chromosome in the mouse karyotype. Chromosoma 89:294, 1984
24. Rowley JD, Diaz MO, Espinosa R, Patel YD, van Melle E, Ziemin S, Le Beau MM: Mapping chromosome band 11q23 in acute leukemia with biotinylated probes: Identification of 11q23 breakpoints within a yeast artifical chromosome. Proc Natl Acad Sci USA 87:9358, 1990
25. Anderson D, Bishop JB, Gamer RC, Ostrosky-Wegman P, Selby PB: Cyclophosphamide: Review of its mutagenicity for an assessment of potential germ cell risks. Mutation Res 330:115, 1995
26. Venkatachalam S, Shi YP, Jones SN, Vogel H, Bradley A, Pinkel D, Donehower LA: Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J 17:4657, 1998
27. Heim R, Silverman L, Farber R, Kam-Morgan L, Luce M: Screening for truncated NF1 proteins. Nat Genet 8:218, 1994
28. Heim R, Kam-Morgan L, Binnie C, Corns D, Cayouette M, Farber R, Aylsworth A, Silverman L, Luce M: Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Human Mol Genet 4:975, 1995
29. Shannon KM, Watterson J, Johnson P, O'Connell P, Lange B, Shah N, Kan YW, Priest JR: Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: Epidemiology and molecular analysis. Blood 79:1311, 1992
30. Smith GS, Walford RL, Mickey MR: Lifespan and incidence of cancer in selected long-lived inbred mice and their F1 hybrids. J Natl Cancer Inst 50:1195, 1973
31. Shoemaker AR, Luongo C, Moser AR, Marton LJ, Dove WF: Somatic mutational mechanisms involved in intestinal tumor formation in Min mice. Cancer Res 57:1999, 1997
32. Luongo C, Moser AR, Gledhill S, Dove WF: Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 54:5847, 1994
33. Takaku T, Oshima M, Miyoshi M, Matsui M, Seldin MF, Taketo M: Intestinal tumorigenesis in compound mutant mice of both Dpc4 and Ape genes. Cell 92:645, 1998
34. Stephens K, Weaver M, Leppig K, Side LE, Shannon KM, Maruyama K: Somatic confined uniparental disomy of the NF1 gene region in myeloid leuekmic cells of an NF1 patient mimics a loss of hetrozygosity due to deletion (abstract). Am J Human Genet 59:A5, 1996 (suppl)
35. Haran-Ghera N, Peled A, Krautghamer R, Resnitzkt P: Initiation and promotion of radiation-induced myeloid leukemia. Leukemia 6:689, 1992
36. Sawyers CL, Denny CT: Chronic myelomonocytic leukemia: tel-a-kinase what ets all about. Cell 77:171, 1994
37. Shannon KM: The Ras signaling pathway and the molecular basis of myeloid leukemogenesis. Curr Opin Hematol 3:305, 1995
38. Pedersen-Bjergaard J, Janssen JWG, Lyons J: Point mutations of the ras protooncogenes and chromosome aberrations in acute nonlymphocytic leukemia and preleukemia related to therapy with alkylating agents. Cancer Res 48:1812, 1988
39. Side LE, Teel K, Wang P, Mahgoub N, Larson R, Le Beau MM, Shannon KM: Activating RAS mutations in therapy-related myeloid disorders associated with deletions of chromosomes 5 and 7 (abstract). Blood 88:566a, 1996 (abstr, suppl 1)